本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ATAI Life Sciences B.V.*

2.25
-0.0300-1.32%
盘后2.25-0.0008-0.04%17:48 EDT
成交量:199.65万
成交额:460.75万
市值:4.52亿
市盈率:-2.41
高:2.40
开:2.30
低:2.23
收:2.28
数据加载中...
2022/03/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/15

重要事件披露

8-K - Current report
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/20

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/11

重要事件披露

8-K - Current report
2021/07/13

重要事件披露

8-K - Current report
2021/06/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/08

SEC问询函

CORRESP [Cover] - Correspondence